Supernus Pharmaceuticals (SUPN) acquires Sage Therapeutics (SAGE), enhancing its CNS portfolio with Zurzuvae's potential.

Contrary to expectations, prolonged water-only fasting increases inflammation and stress on the body, despite weight loss.

Axpaxli is Ocular's main value driver, targeting a large wet AMD market with a differentiated, sustained-release TKI ...

DataM Intelligence | competitive Intelligence Uveal Melanoma enters a new era with novel therapies like KIMMTRAK and HEPZATO, as next-gen t ...

An anti-inflammatory diet can counteract chronic low-grade inflammation by modulating immune responses, gut health, and key ...

The PD-L1 Inhibitors drugs uptake section examines the rate at which newly launched or upcoming potential drugs are being ...